For the last 7 years, we’ve helped drug companies get their products through regulatory agencies in the US, Europe, Japan, and beyond. CROs are great at running trials on a big scale, but when the real hurdle is the regulator, a specialist team like ours often moves things forward faster and with fewer headaches. What We Do, Day to Day Phortas only handles your regulatory work. That means: Writing briefing packages and running practice sessions for FDA, EMA, or PMDA meetings.

We are proud to share that Dr. Darius-Jean Namdjou, Director and Senior Regulatory Lead at Phortas, participated in the General Assembly Meeting of ERDERA, held from 29–31 October 2025 at the Amsterdam University Medical Center (UMC). ERDERA – the European Rare Diseases Research Alliance  – is a European partnership that unites over 170 public and private organisations across 37 countries around a common goal: transforming cutting-edge science into tangible benefits for the t